Skip to main content
Erschienen in: Rheumatology International 1/2017

24.11.2016 | Observational Research

High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound

verfasst von: Rosario Ibáñez-Bosch, Juliana Restrepo-Velez, Miguel Medina-Malone, Laura Garrido-Courel, Inmaculada Paniagua-Zudaire, Eduardo Loza-Cortina

Erschienen in: Rheumatology International | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Analyse the presence of subclinical atherosclerosis in psoriatic arthritis patients (PsA). A cross-sectional study of 53 patients with PsA and 53 controls matched for age and sex was designed. Carotid intima-media thickness (IMT) and the presence of carotid plaques (CP) were assessed with carotid ultrasound. Data on cardiovascular (CV) risk factors were collected. Patients with PsA had a higher prevalence rate of obesity and tobacco smoking. CP were detected more frequently in patients with PsA than in controls with an OR of 4.15, 95% CI 1.4–12.1, which adjusted for smoking and those with history of CV disease gave an OR of 3.9, 95% CI 1.2–12.7, p = 0.026. Carotid IMT was significantly higher in patients with PsA adjusted for age and tobacco smoking. According to ultrasound data, 30.2% of patients with PsA had carotid atherosclerosis (presence of CP and/or carotid IMT > 0.90 mm) compared with 9.4% of controls. The SCORE index (Systematic Coronary Risk Evaluation) underestimated the CV risk in these patients: most patients with CP had an intermediate CV risk. According to carotid ultrasound data, PsA patients have a high prevalence of subclinical atherosclerosis. These results support the importance of screening for CV risk and to include carotid ultrasound in CV prevention strategies in these patients.
Literatur
1.
Zurück zum Zitat Shen J, Shang Q, Li EK et al (2015) Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study. Arthritis Res Ther 17:75CrossRefPubMedPubMedCentral Shen J, Shang Q, Li EK et al (2015) Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study. Arthritis Res Ther 17:75CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Tam LS, Tomlinson B, Chu TT et al (2008) Cardiovascular risk profile of patients with psoriatic arthritis compared to controls: the role of inflammation. Rheumatol (Oxf) 47:718–723CrossRef Tam LS, Tomlinson B, Chu TT et al (2008) Cardiovascular risk profile of patients with psoriatic arthritis compared to controls: the role of inflammation. Rheumatol (Oxf) 47:718–723CrossRef
3.
Zurück zum Zitat Castañeda S, Martín-Martínez MA, González-Juanatey C et al (2015) Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA Project. Semin Arthritis Rheum 44(6):618–626CrossRefPubMed Castañeda S, Martín-Martínez MA, González-Juanatey C et al (2015) Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA Project. Semin Arthritis Rheum 44(6):618–626CrossRefPubMed
4.
Zurück zum Zitat Ogdie A, Yu Y, Haynes K et al (2015) Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 74(2):326–332CrossRefPubMed Ogdie A, Yu Y, Haynes K et al (2015) Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 74(2):326–332CrossRefPubMed
5.
Zurück zum Zitat Martín-Martínez MA, González-Juanatey C, Castañeda S et al (2014) Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion. Semin Arthritis Rheum 44(1):1–8CrossRefPubMed Martín-Martínez MA, González-Juanatey C, Castañeda S et al (2014) Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion. Semin Arthritis Rheum 44(1):1–8CrossRefPubMed
6.
Zurück zum Zitat Peters MJL, Symmons DPM, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325–331CrossRefPubMed Peters MJL, Symmons DPM, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325–331CrossRefPubMed
7.
Zurück zum Zitat Horreau C, Ponplard C, Brenaut E, Barnetche T, Misery L, Cribier B et al (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venerol. 27:12–29CrossRef Horreau C, Ponplard C, Brenaut E, Barnetche T, Misery L, Cribier B et al (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venerol. 27:12–29CrossRef
8.
Zurück zum Zitat Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA (2007) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheumatol 57:1074–1080CrossRef Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA (2007) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheumatol 57:1074–1080CrossRef
9.
Zurück zum Zitat Ernste FC, Sánchez-Menéndez M, Wilton KM, Crowson CS, Matteson EL, Maradit Kremers H (2015) Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study: PsA and risk of CVD. Arthritis Care Res 67(7):1015–1021CrossRef Ernste FC, Sánchez-Menéndez M, Wilton KM, Crowson CS, Matteson EL, Maradit Kremers H (2015) Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study: PsA and risk of CVD. Arthritis Care Res 67(7):1015–1021CrossRef
10.
Zurück zum Zitat Khraishi M, Aslanov R, Rampakakis E, Pollock C, Sampalis JS (2014) Prevalence of cardiovascular risk factors in patients with psoriatic arthritis. Clin Rheumatol 33:1495–1500CrossRefPubMed Khraishi M, Aslanov R, Rampakakis E, Pollock C, Sampalis JS (2014) Prevalence of cardiovascular risk factors in patients with psoriatic arthritis. Clin Rheumatol 33:1495–1500CrossRefPubMed
11.
Zurück zum Zitat Yilmazer B, Sahin T, Unlu BÖ, Kir HM, Cefle A (2015) Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity. Rheumatol Int 35(8):1385–1392CrossRefPubMed Yilmazer B, Sahin T, Unlu BÖ, Kir HM, Cefle A (2015) Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity. Rheumatol Int 35(8):1385–1392CrossRefPubMed
13.
Zurück zum Zitat Eder L, Zisman D, Barzilai M et al (2008) Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 35:877–882PubMed Eder L, Zisman D, Barzilai M et al (2008) Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 35:877–882PubMed
14.
Zurück zum Zitat Tam LS, Shang Q, Li EK et al (2008) Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheumatol 59:1322–1331CrossRef Tam LS, Shang Q, Li EK et al (2008) Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheumatol 59:1322–1331CrossRef
16.
Zurück zum Zitat Conroy RM, Pyörölä K, Fitzgerald AP et al (2003) Estimation of ten-years risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003CrossRefPubMed Conroy RM, Pyörölä K, Fitzgerald AP et al (2003) Estimation of ten-years risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003CrossRefPubMed
17.
Zurück zum Zitat Toutboul PJ, Hennerici MG, Maairs S et al (2004) Mannheim intima-media thickness consensus. Cerebrovasc Dis 18:346–349CrossRef Toutboul PJ, Hennerici MG, Maairs S et al (2004) Mannheim intima-media thickness consensus. Cerebrovasc Dis 18:346–349CrossRef
19.
Zurück zum Zitat Højgaard P, Glintborg P, Hetland ML, Hansen TH, Lage-Hansen PR, Peterson MH (2015) Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DAMBIO registry. Ann Rheum Dis 74:2130–2136CrossRefPubMed Højgaard P, Glintborg P, Hetland ML, Hansen TH, Lage-Hansen PR, Peterson MH (2015) Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DAMBIO registry. Ann Rheum Dis 74:2130–2136CrossRefPubMed
20.
Zurück zum Zitat Belcaro G, Nicolaides AN, Ramaswami G et al (2001) Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study (1)). Atherosclerosis 156:379–387CrossRefPubMed Belcaro G, Nicolaides AN, Ramaswami G et al (2001) Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study (1)). Atherosclerosis 156:379–387CrossRefPubMed
21.
Zurück zum Zitat Tejón P, Morante I, Cabezas I, Sarasqueta C, Coto P, Queiro R (2016) A polyarticular onset and diabetes could be the main predictors of cardiovascular events in psoriatic arthritis. Clin Exp Rheumatol 34(2):276–281PubMed Tejón P, Morante I, Cabezas I, Sarasqueta C, Coto P, Queiro R (2016) A polyarticular onset and diabetes could be the main predictors of cardiovascular events in psoriatic arthritis. Clin Exp Rheumatol 34(2):276–281PubMed
22.
Zurück zum Zitat Gulati AM, Semb AG, Rollefstad S, Romundstad PR, Kavanaugh A, Gulati S (2016) On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study. Ann Rheum Dis 75:819–824CrossRefPubMed Gulati AM, Semb AG, Rollefstad S, Romundstad PR, Kavanaugh A, Gulati S (2016) On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study. Ann Rheum Dis 75:819–824CrossRefPubMed
23.
Zurück zum Zitat Arts EE, Popa CD, Den AA et al (2016) Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Ann Rheum Dis 75:674–680CrossRefPubMed Arts EE, Popa CD, Den AA et al (2016) Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Ann Rheum Dis 75:674–680CrossRefPubMed
24.
Zurück zum Zitat Rosales Alexander JL, Cantero-Hinojosa J, Salvatierra J et al (2014) Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evidence cardiovascular disease or classic atherosclerosis risk factors. Joint Bone Spine 81:164–168CrossRefPubMed Rosales Alexander JL, Cantero-Hinojosa J, Salvatierra J et al (2014) Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evidence cardiovascular disease or classic atherosclerosis risk factors. Joint Bone Spine 81:164–168CrossRefPubMed
25.
Zurück zum Zitat Kimhi O, Caspi D, Bornstein NM et al (2007) Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 36(4):203–209CrossRefPubMed Kimhi O, Caspi D, Bornstein NM et al (2007) Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 36(4):203–209CrossRefPubMed
Metadaten
Titel
High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound
verfasst von
Rosario Ibáñez-Bosch
Juliana Restrepo-Velez
Miguel Medina-Malone
Laura Garrido-Courel
Inmaculada Paniagua-Zudaire
Eduardo Loza-Cortina
Publikationsdatum
24.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 1/2017
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3617-x

Weitere Artikel der Ausgabe 1/2017

Rheumatology International 1/2017 Zur Ausgabe

Original Article - Observational Research

Lipid profile among girls with systemic lupus erythematosus

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.